Systematic Evolution of Ligands by Exponential Enrichment

Systematic evolution of ligands by exponential enrichment, commonly abbreviated SELEX, is a combinatorial molecular biology method for discovering aptamers: short, usually single-stranded DNA or RNA molecules that fold into three-dimensional structures capable of binding particular targets. It is a laboratory technique rather than a conventional commercial brand, company, product line, or consumer-facing service. The method is also described as in vitro selection or in vitro evolution, while related terminology has included SAAB and CASTing. A typical SELEX experiment begins with a very large library of chemically synthesized oligonucleotides. Each sequence contains a randomized central region flanked by constant primer-binding regions. The randomized portion provides structural and sequence diversity, while the constant ends enable amplification and, for RNA selections, transcription. In principle, a randomized region of length n can contain 4^n conventional DNA or RNA sequences, although practical library size is far smaller because synthesis, amplification, handling, and sampling impose limits. The starting pool is converted into single-stranded molecules and folded under conditions chosen for the intended target and application. The library is then exposed to a target. Targets may include proteins, nucleic acids, metabolites, drugs, other small molecules, or intact cells. In the classical format, the target is immobilized on a chromatographic matrix, membrane, or paramagnetic bead. Molecules that do not bind are washed away, while retained sequences are eluted and amplified. DNA selections generally use PCR directly; RNA selections typically require reverse transcription, PCR, and in vitro transcription before the next cycle. Producing a clean single-stranded pool for the subsequent round is a central technical requirement and may involve asymmetric PCR, strand capture using biotin, or selective enzymatic degradation. The binding, washing, elution, and amplification cycle is repeated under progressively more selective conditions. Researchers can reduce target concentration, shorten incubation time, increase washing stringency, or alter buffer conditions to favor tighter or more selective binders. Counter-selection can be introduced against an immobilization matrix, related molecules, unwanted proteins, or non-target cell types. This removes sequences that bind nonspecifically and can improve discrimination between closely related targets. Selection progress may be monitored by measuring the amount or fraction of the library retained in each round, followed by sequencing and characterization of enriched candidates. SELEX has supported the development of aptamers for biosensors, analytical assays, imaging, diagnostics, affinity purification, and therapeutic research. Aptamers are often compared with antibody reagents because both can recognize molecular targets, but aptamers are made by chemical synthesis and can be selected against targets that are difficult to use in conventional immunization. Their properties can be tuned through buffer conditions, counter-selection, truncation, chemical modification, and post-selection engineering. However, very high apparent affinity does not automatically produce the best specificity; an aptamer may still recognize related molecules or exhibit undesirable interactions in complex biological settings. Later developments expanded the chemical and operational scope of SELEX. Modified sugars and bases can increase nuclease resistance, stability in serum, hydrophobic interactions, and structural diversity. Unnatural base pairs have also been incorporated into selection systems to enlarge the accessible chemical alphabet. Cell-based selections allow libraries to be screened against whole cells rather than purified targets. Other approaches seek to avoid target immobilization, which can conceal binding sites or be especially problematic for small molecules. One such related approach is FRELEX, described as a non-immobilizing selection strategy. Despite these innovations, SELEX remains constrained by the enormous size of theoretical oligonucleotide sequence space and by biases introduced during synthesis, amplification, partitioning, and selection.

SELEX emerged in 1990 during the development of in vitro methods for selecting nucleic-acid molecules with desired binding properties. Its central insight was that a synthetic pool containing many different DNA or RNA sequences could be subjected to repeated cycles of binding-based enrichment. Rather than designing every sequence individually, researchers could allow the target to select compatible structures from a large combinatorial population and then amplify the retained candidates for another round. The original workflow used randomized oligonucleotide libraries flanked by constant regions. These fixed regions provided primer sites for amplification, while the randomized segments generated the structural diversity needed for target recognition. After conversion to single-stranded form, the library was incubated with a selected target. Binding sequences were separated from non-binding sequences, recovered, amplified, and returned to the next selection cycle. Repetition caused target-binding sequences to become increasingly represented in the pool. The resulting molecules became known as aptamers. Several technical issues shaped the evolution of the method. Chemical synthesis can generate extremely large pools, but the theoretical sequence space is much larger than any experimentally manageable library. Polymerase chain reaction can introduce amplification bias, and defects in synthesis can remove or underrepresent potentially useful sequences. Maintaining single-stranded material is also essential because aptamer activity depends on the molecule adopting an appropriate secondary and tertiary structure. Researchers consequently developed alternative strand-separation procedures, including asymmetric PCR, biotin-based capture, and enzymatic degradation of one strand. Target presentation became another major area of variation. Purified proteins or small molecules may be attached to chromatography media, membranes, or magnetic particles, but immobilization can alter a target’s conformation or hide an epitope. Cell-SELEX extended the approach to intact cells, enabling selection for cell-surface features in a more complex biological context. Counter-selection was added to remove sequences that recognize the support material, related compounds, irrelevant cells, or other unwanted components. Buffer composition, temperature, salt concentration, incubation time, target abundance, and washing conditions can all be adjusted to change the selection pressure. SELEX subsequently became a broad family of related protocols rather than a single rigid procedure. RNA and DNA selections were joined by workflows using modified sugars, modified bases, and expanded genetic alphabets. These changes were intended to improve resistance to nucleases, increase stability in biological fluids, create new chemical interactions, or generate more diverse three-dimensional structures. Primer regions could also influence folding, leading to efforts to reduce or remove their contribution when short, self-sufficient aptamers were desired. The method found uses across analytical chemistry, biosensor design, molecular recognition, diagnostics, imaging, affinity reagents, and therapeutic research. Aptamers can be chemically synthesized and modified after selection, but successful laboratory binding does not by itself establish clinical utility. Specificity, biological stability, delivery, pharmacokinetics, nonspecific interactions, and performance in complex samples remain application-specific challenges. In particular, selecting for extremely tight binding can sometimes increase recognition of related off-target molecules rather than improve practical selectivity. Modern selection systems continue to address the limits of conventional SELEX. The experimentally accessible library is tiny compared with the full theoretical space of possible oligonucleotide sequences, and enrichment can be distorted by sequence composition, PCR behavior, folding, and partitioning artifacts. Non-immobilizing approaches such as FRELEX were developed to reduce problems caused by attaching targets to a solid phase. Computational structure prediction, high-throughput sequencing, and machine-learning-assisted analysis can further help researchers track enrichment and identify promising sequence families. Nevertheless, the repeated principle of library generation, selective retention, recovery, and amplification remains the defining foundation of SELEX.

• 2016

  FRELEX is described

  [1]Systematic evolution of ligands by exponential enrichmenten.wikipedia.org

  A related non-immobilizing aptamer-selection approach is developed to address limitations associated with target immobilization.

• 2015

  Twenty-five-year recognition of the method

  [1]Systematic evolution of ligands by exponential enrichmenten.wikipedia.org

  A special issue of the Journal of Molecular Evolution commemorates roughly a quarter century of SELEX research and development.

• 1990

  SELEX is introduced

  [1]Systematic evolution of ligands by exponential enrichmenten.wikipedia.org

  The in vitro selection method is introduced for isolating DNA or RNA sequences that bind selected targets from large randomized oligonucleotide libraries.

A foundational in vitro evolution platform for discovering synthetic nucleic-acid binders with applications in research, diagnostics, biosensing, and therapeutic development.

• Synthetic nucleic-acid binders · 1990

  DNA aptamers

  Single-stranded DNA molecules selected from randomized libraries for binding to a specified target. They can be used as affinity reagents, sensor elements, assay components, or research probes and may be chemically modified after selection.

• Synthetic nucleic-acid binders · 1990

  RNA aptamers

  Single-stranded RNA molecules generated through transcription-linked selection cycles. Their folding can create target-binding structures, while chemical modification may be used to improve stability or resistance to degradation.

• Modified oligonucleotide reagents

  Chemically modified aptamers

  Aptamers incorporating modified sugars, bases, or expanded base-pair systems. These formats are intended to broaden chemical diversity, strengthen selected interactions, improve nuclease resistance, or enhance performance in biological environments.

• Cell-based selection technology

  Cell-SELEX reagents and workflows

  SELEX variants that use intact cells as selection targets. They can enrich sequences recognizing cell-surface molecules or cellular phenotypes without requiring complete purification and immobilization of the target.

• 1990

  Adoption of iterative in vitro selection and amplificationStrategy

  Background

  The method was established around repeated enrichment of target-binding sequences from a randomized oligonucleotide pool.

  Action taken

  Researchers combined target incubation, separation of retained sequences, nucleic-acid amplification, and reuse of the enriched pool in successive rounds.

  Aftermath

  The workflow became a general platform for discovering aptamers against molecular and cellular targets.

  Source

• Expansion into modified-nucleotide and alternative selection formatsStrategy

  Background

  Classical SELEX can be limited by target immobilization, nuclease instability, primer-dependent folding, and the restricted chemical diversity of standard nucleotides.

  Action taken

  Researchers developed counter-selection, cell-based selection, chemically modified libraries, expanded genetic alphabets, and non-immobilizing approaches such as FRELEX.

  Aftermath

  The SELEX family became adaptable to a wider range of targets and intended applications, although library and selection biases remained important constraints.

  Source

1. 1Systematic evolution of ligands by exponential enrichmenten.wikipedia.org